Table 1.
Baseline characteristics of patients.
| Characteristics | All Patients (n = 286) |
|---|---|
| Gender, n (%) | |
| women | 186 (65%) |
| men | 100 (35%) |
| Age, years (mean ± sd) | 67.22 ± 10.13 |
| Weight, kg (mean ± sd) | 84.6 ± 18.95 |
| BMI (mean ± sd) | 30.89 ± 6.15 |
| GFR, mL/min (mean ± sd) | 72.09 ± 20.08 |
| Grade of arterial hypertension, n (%) | |
| 1 | 10 (3.5%) |
| 2 | 46 (16.1%) |
| 3 | 230 (80.4%) |
| CAD, n (%) | 140 (49%) |
| CHF, n (%) | 110 (38.5%) |
| AF, n (%) | 97 (33.9%) |
| DM type 2, n (%) | 93 (32.5%) |
| Dislipidemia, n (%) | 128 (44.8%) |
| Single enalapril dose, n (%): | |
| 2.5 mg | 55 (19.2%) |
| 5 mg | 121 (42.3%) |
| 7.5 mg | 14 (4.9%) |
| 10 mg | 69 (24.1%) |
| 12.5 mg | 2 (0.7%) |
| 15 mg | 9 (3.1%) |
| 20 mg | 16 (5.6%) |
AF—atrial fibrillation, BMI—body mass index, CAD—coronary artery disease, CHF—chronic heart failure, DM—diabetes mellitus, GFR—glomerular filtration rate, sd—standard deviation.